77
Participants
Start Date
December 31, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Duloxetine
54 participants will be allocated for duloxetine treatment
Remifentanil
27 participants will be allocated to Remifentanil infusion
Placebo (for Remifentanil)
Placebo comparator to Remifentanil treatment. 27 participants will be allocated to this arm
Placebo (for Duloxetine)
Sugar pill manufactured to mimic Duloxetine 30mg. 27 participants will be allocated to this intervention
University of Nottingham - School of Medicine - Radiological Sciences, Nottingham
Arthritis Research UK
OTHER
University of Nottingham
OTHER